Crispr
FDA Approves a CRISPR-Based Medicine to Treat Sickle Cell Disease
2023-12-08 20:01:49
by
Dan McCue
WASHINGTON — The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology for the treatment of sickle cell disease. The new treatment, called Casgevy, was manufactured by Vertex Pharmaceuticals, of Boston, Massachusetts, and... Read More
Straight From The Well
